--- product_id: 7931048 title: "Surviving \"Terminal\" Cancer: Clinical Trials, Drug Cocktails, and Other Treatments Your Oncologist Won't Tell You About" price: "VT8336" currency: VUV in_stock: true reviews_count: 13 url: https://www.desertcart.vu/products/7931048-surviving-terminal-cancer-clinical-trials-drug-cocktails-and-other-treatments store_origin: VU region: Vanuatu --- # Surviving "Terminal" Cancer: Clinical Trials, Drug Cocktails, and Other Treatments Your Oncologist Won't Tell You About **Price:** VT8336 **Availability:** ✅ In Stock ## Quick Answers - **What is this?** Surviving "Terminal" Cancer: Clinical Trials, Drug Cocktails, and Other Treatments Your Oncologist Won't Tell You About - **How much does it cost?** VT8336 with free shipping - **Is it available?** Yes, in stock and ready to ship - **Where can I buy it?** [www.desertcart.vu](https://www.desertcart.vu/products/7931048-surviving-terminal-cancer-clinical-trials-drug-cocktails-and-other-treatments) ## Best For - Customers looking for quality international products ## Why This Product - Free international shipping included - Worldwide delivery with tracking - 15-day hassle-free returns ## Description An account of dealing with glioblastoma brain cancer, along with the information needed to survive it Review: Very interesting and informative - A critical perspective of the cancer industry from a very intelligent patient. Good for thought of you ever have to deal with cancer. Review: A New Approach, A New Attitude - I found this book inspirational. Not because the author beat the odds in surviving a cancer considered "terminal" by all of his physicians, but because he did it by rationally setting out to explore all of his options and did not just let the "experts" tell him what to do. The most important lesson from this book for those of us exploring cancer/tumor treatment options is that we have to research beyond what we are likely to hear from our medical specialists. Each of them will have their particular bias (e.g., surgeons tend to want to cut things out, oncologists will tend towards other strategies). Moreover, as the author points out, the range of treatments the medical specialists are willing to recommend are sharply limited by custom to things that have passed the FDA-mandated stage III clinical trials. Many very promising treatments have only passed stage II trials; and because of cost, never go beyond that. Nor do medical specialists in the U.S. look at successful treatments that are well-accepted by the medical specialists in other countries. And while this book does discuss "alternative" medicine, that is not the focus. The author does evaluate some "alternative" medical approaches, debunking several of them but also notes where medical science has validated some of them. Another critical point the author makes is that treating cancer should be like treating AIDs. Because of the probabilistic nature of any single treatment successfully eradicating a cancer, a "cocktail-style" drug regiment has the best chance of succeeding. He makes a powerful and convincing argument that this one change in approach could make a huge difference in reducing the recurrence of cancer and boosting the effectiveness of current treatments. One more key insight of the author: the large pharmaceutical companies have no financial incentive to pursue promising cancer treatments that they can not patent and thereby recoup their multi-billion dollar investment. Because of that, the author believes many promising treatments are not fully explored. He is sharply critical of government policies that have not closed this gap. CFC ## Technical Specifications | Specification | Value | |---------------|-------| | Best Sellers Rank | #118,406 in Books ( See Top 100 in Books ) #36 in Oncology (Books) | | Customer Reviews | 4.6 out of 5 stars 281 Reviews | ## Images ![Surviving "Terminal" Cancer: Clinical Trials, Drug Cocktails, and Other Treatments Your Oncologist Won't Tell You About - Image 1](https://m.media-amazon.com/images/I/61e6PF2i0nL.jpg) ## Customer Reviews ### ⭐⭐⭐⭐⭐ Very interesting and informative *by J***S on April 2, 2025* A critical perspective of the cancer industry from a very intelligent patient. Good for thought of you ever have to deal with cancer. ### ⭐⭐⭐⭐⭐ A New Approach, A New Attitude *by P***S on September 4, 2006* I found this book inspirational. Not because the author beat the odds in surviving a cancer considered "terminal" by all of his physicians, but because he did it by rationally setting out to explore all of his options and did not just let the "experts" tell him what to do. The most important lesson from this book for those of us exploring cancer/tumor treatment options is that we have to research beyond what we are likely to hear from our medical specialists. Each of them will have their particular bias (e.g., surgeons tend to want to cut things out, oncologists will tend towards other strategies). Moreover, as the author points out, the range of treatments the medical specialists are willing to recommend are sharply limited by custom to things that have passed the FDA-mandated stage III clinical trials. Many very promising treatments have only passed stage II trials; and because of cost, never go beyond that. Nor do medical specialists in the U.S. look at successful treatments that are well-accepted by the medical specialists in other countries. And while this book does discuss "alternative" medicine, that is not the focus. The author does evaluate some "alternative" medical approaches, debunking several of them but also notes where medical science has validated some of them. Another critical point the author makes is that treating cancer should be like treating AIDs. Because of the probabilistic nature of any single treatment successfully eradicating a cancer, a "cocktail-style" drug regiment has the best chance of succeeding. He makes a powerful and convincing argument that this one change in approach could make a huge difference in reducing the recurrence of cancer and boosting the effectiveness of current treatments. One more key insight of the author: the large pharmaceutical companies have no financial incentive to pursue promising cancer treatments that they can not patent and thereby recoup their multi-billion dollar investment. Because of that, the author believes many promising treatments are not fully explored. He is sharply critical of government policies that have not closed this gap. CFC ### ⭐⭐⭐⭐⭐ 411 on Brain Cancer Help *by T***J on February 1, 2026* Very informative! --- ## Why Shop on Desertcart? - 🛒 **Trusted by 1.3+ Million Shoppers** — Serving international shoppers since 2016 - 🌍 **Shop Globally** — Access 737+ million products across 21 categories - 💰 **No Hidden Fees** — All customs, duties, and taxes included in the price - 🔄 **15-Day Free Returns** — Hassle-free returns (30 days for PRO members) - 🔒 **Secure Payments** — Trusted payment options with buyer protection - ⭐ **TrustPilot Rated 4.5/5** — Based on 8,000+ happy customer reviews **Shop now:** [https://www.desertcart.vu/products/7931048-surviving-terminal-cancer-clinical-trials-drug-cocktails-and-other-treatments](https://www.desertcart.vu/products/7931048-surviving-terminal-cancer-clinical-trials-drug-cocktails-and-other-treatments) --- *Product available on Desertcart Vanuatu* *Store origin: VU* *Last updated: 2026-05-12*